title: Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. Veterans Administration Cooperative Study on Treatment of Alcoholic Cirrhosis with Ascites.
abstract: The optimal management of severe ascites in patients with alcoholic cirrhosis has not been defined. in a 5 1/2-year study, we randomly assigned 299 men with alcoholic cirrhosis, who had persistent or recurrent severe ascites despite a standard medical regimen, to receive either intensive medical treatment or peritoneovenous (LeVeen) shunting. We identified three risk groups: Group 1 had normal or mildly abnormal results on liver-function tests, Group 2 had more severe liver dysfunction or previous complications, and Group 3 had severe prerenal azotemia without kidney disease. For the patients who received the medical treatment and those who received the surgical treatment combined, the median survival times were 1093 days in Group 1, 222 days in Group 2, and 37 days in Group 3 (P less than or equal to 0.01) for all comparisons). For all the groups combined, the median time to the resolution of ascites was 5.4 weeks for medical patients and 3.0 weeks for surgical patients (P less than 0.01). Within each risk group, mortality during the initial hospitalization and median long-term survival were similar among patients receiving either treatment. However, the median time to the recurrence of ascites in Group 1 was 4 months in medical patients, as compared with 18 months in surgical patients (P = 0.01); in Group 2 it was 3 months in medical patients as compared with 12 months in surgical patients (P = 0.04). The median duration of hospitalization was longer in medical patients than in surgical patients (6.1 vs. 2.4 weeks in Group 1 [P less than 0.001] and 5.0 vs. 3.1 weeks in Group 2 [P less than 0.01]). Group 3 was too small to permit a meaningful comparison. During the initial hospitalization, the incidence of infections, gastrointestinal bleeding, and encephalopathy was similar among the medical and surgical patients. We conclude that peritoneovenous shunting alleviated disabling ascites more rapidly than medical management. However, survival was closely related to the severity of the illness at the time of randomization and was not altered by shunting.
authors.affiliation: VA Medical Center, Hines, IL 60141.
authors.forename: M M
authors.initials: MM
authors.lastname: Stanley
authors.forename: S
authors.initials: S
authors.lastname: Ochi
authors.forename: K K
authors.initials: KK
authors.lastname: Lee
authors.forename: B A
authors.initials: BA
authors.lastname: Nemchausky
authors.forename: H B
authors.initials: HB
authors.lastname: Greenlee
authors.forename: J I
authors.initials: JI
authors.lastname: Allen
authors.forename: M J
authors.initials: MJ
authors.lastname: Allen
authors.forename: R A
authors.initials: RA
authors.lastname: Baum
authors.forename: T R
authors.initials: TR
authors.lastname: Gadacz
authors.forename: D S
authors.initials: DS
authors.lastname: Camara
mesh_terms: D001201:Ascites / Q000209:etiology / Q000628:therapy*; D005500:Follow-Up Studies; D006801:Humans; D007902:Length of Stay; D008104:Liver Cirrhosis, Alcoholic / Q000150:complications / Q000401:mortality / Q000628:therapy*; D010536:Peritoneovenous Shunt; D011897:Random Allocation; D013997:Time Factors